Publications by authors named "Jorge Mario Sanchez-Caraballo"
Introduction: Up to 25% of children and 5.6% of adults in the USA have atopic dermatitis (AD), with substantial impacts on quality of life. Effective control can be challenging despite therapy efforts.
View Article and Find Full Text PDFArticle Synopsis
- Chronic urticaria (CU) is frequently managed with Omalizumab in cases where antihistamines are ineffective, but little research has focused on its use in Latin America, particularly in Colombia.
- A study was conducted with 123 patients in Colombia from 2014 to 2017, primarily consisting of women (73.1%) with an average age of 47.1 years, where most patients were diagnosed with chronic spontaneous urticaria.
- Emotional factors such as anxiety and stress were significant among patients, with 34.9% reporting anxiety symptoms and 34.1% experiencing exacerbations due to stress, highlighting the psychological aspect of CU management.
Introduction: Previous evidence has shown that fractional exhaled nitric oxide (FeNO) and eosinophil count in induced sputum (EO) are cost-effective relative to standard of care in guiding the management of children with persistent asthma. There is some doubt as if there are differences between these two biomarkers in terms of costs and benefits. Clarifying this doubt would allow prioritization of the design of clinical practice guidelines.
View Article and Find Full Text PDFPurpose Of Review: Since omalizumab has been approved for urticaria, numerous randomized and real-life observational trials have been published. We reviewed the period January 2017-February 2018.
Recent Findings: Omalizumab is effective for the control of urticaria recalcitrant to antihistamines in different populations globally.
Background: Allergen immunotherapy has demonstrated usefulness in the management of allergic diseases such as asthma, allergic rhinitis and conjunctivitis. However, little is known about its effectiveness in vernal keratoconjunctivitis (VKC), a disease mediated by IgE and lymphocytes, that can cause loss of visual acuity in a permanent way.
Objective: To describe safety and effectiveness of allergen immunotherapy in a group of patients with VKC.
Background. Immunotherapy has proven to be an useful tool in the management of allergic respiratory diseases; however, little has been studied in atopic dermatitis. Objective.
View Article and Find Full Text PDF